305 related articles for article (PubMed ID: 20493219)
1. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.
Hu YL; Fu YH; Tabata Y; Gao JQ
J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219
[TBL] [Abstract][Full Text] [Related]
2. [Research progress of gene recombinant mesenchymal stem cells as tumor targeting delivery vehicles].
Zhang TY; Hu YL; Liang WQ; Gao JQ
Yao Xue Xue Bao; 2013 Aug; 48(8):1209-20. PubMed ID: 24187826
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
5. Baculovirus-mediated gene transfer into mesenchymal stem cells.
Tsai CT; Chuang CK; Hu YC
Methods Mol Biol; 2009; 515():339-51. PubMed ID: 19378120
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene-delivery strategies for angiostatic cancer treatment.
Brandwijk RJ; Griffioen AW; Thijssen VL
Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
[TBL] [Abstract][Full Text] [Related]
7. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells.
Park JS; Na K; Woo DG; Yang HN; Kim JM; Kim JH; Chung HM; Park KH
Biomaterials; 2010 Jan; 31(1):124-32. PubMed ID: 19818490
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells.
Santos JL; Pandita D; Rodrigues J; Pêgo AP; Granja PL; Balian G; Tomás H
Mol Pharm; 2010 Jun; 7(3):763-74. PubMed ID: 20230026
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery to mesenchymal stem cells.
Izadpanah R; Bunnell BA
Methods Mol Biol; 2008; 449():153-67. PubMed ID: 18370090
[TBL] [Abstract][Full Text] [Related]
10. Potential implications of mesenchymal stem cells in cancer therapy.
Dai LJ; Moniri MR; Zeng ZR; Zhou JX; Rayat J; Warnock GL
Cancer Lett; 2011 Jun; 305(1):8-20. PubMed ID: 21396770
[TBL] [Abstract][Full Text] [Related]
11. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
12. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
13. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy.
Li L; Guan Y; Liu H; Hao N; Liu T; Meng X; Fu C; Li Y; Qu Q; Zhang Y; Ji S; Chen L; Chen D; Tang F
ACS Nano; 2011 Sep; 5(9):7462-70. PubMed ID: 21854047
[TBL] [Abstract][Full Text] [Related]
14. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.
Scherer F; Anton M; Schillinger U; Henke J; Bergemann C; Krüger A; Gänsbacher B; Plank C
Gene Ther; 2002 Jan; 9(2):102-9. PubMed ID: 11857068
[TBL] [Abstract][Full Text] [Related]
15. An hydrophobically modified arginine peptide vector system effectively delivers DNA into human mesenchymal stem cells and maintains transgene expression with differentiation.
Kim NY; Choi YB; Kang CI; Kim HH; Yang JM; Shin S
J Gene Med; 2010 Sep; 12(9):779-89. PubMed ID: 20821748
[TBL] [Abstract][Full Text] [Related]
16. Lipidic vector systems for gene transfer.
Lee RJ; Huang L
Crit Rev Ther Drug Carrier Syst; 1997; 14(2):173-206. PubMed ID: 9107521
[TBL] [Abstract][Full Text] [Related]
17. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
Wang J; Tao X; Zhang Y; Wei D; Ren Y
Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
[TBL] [Abstract][Full Text] [Related]
18. Modular protein engineering for non-viral gene therapy.
Arís A; Villaverde A
Trends Biotechnol; 2004 Jul; 22(7):371-7. PubMed ID: 15245910
[TBL] [Abstract][Full Text] [Related]
19. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics.
Huang Z; Pei N; Wang Y; Xie X; Sun A; Shen L; Zhang S; Liu X; Zou Y; Qian J; Ge J
Biomaterials; 2010 Mar; 31(8):2130-40. PubMed ID: 19995668
[TBL] [Abstract][Full Text] [Related]
20. [Current progress in researches on the gene delivery systems based on nanoparticles technology].
Qi X; Xu H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1376-9. PubMed ID: 20095507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
